MedPath

Combined effects of inspiratory and expiratory muscle training on pulmonary function and disease severity in patients with pneumonia

Not Applicable
Conditions
Pneumonia.
Pneumonia, Inspiratory muscle training, Expiratory muscle training, Pulmonary function, The Breather, Diaphragmatic Breathing
Registration Number
IRCT20230622058556N1
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

•Adults aged 35-55 years
•Patients having stage 2 to 4 according to pneumonia severity index
•Participants willing to be the part of the research
•Both gender male and female

Exclusion Criteria

•Participant with acute heart disease (Heart Failure) and acute coronary artery disease
•Participants with other respiratory condition
•Participants with the diseases leading to the impairment of respiratory muscle (Mysthenia Gravis)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pulmonary function. Timepoint: The Primary outcomes will be measured at two points before starting the treatment and after the treatment ends. Method of measurement: Pulmonary function will be assessed through digital spirometer (FEV1, FVC, FEV1/FVC).;Disease Severity. Timepoint: The Primary outcomes will be measured at two points before starting the treatment and after the treatment ends. Method of measurement: disease severity through Pneumonia Severity index, and Modified Borg scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath